PeriNess Ltd. is a biopharmaceutical company that is committed to, and engaged in the development of a new drug for enhancement of male fertility. The company has discovered a unique enzyme, DNase I, that can significantly enhance the fertility of sub-fertile males
Male subfertility is any health issue in a man that lowers the chances of his female partner getting pregnant.
A man’s fertility generally depends on the quantity and quality of his sperm.
One couple out of five experience difficulty in conceiving. In about half of all sub-fertile couples, male sub-fertility is observed, and in almost 40% of such couples the sub-fertility is solely due to male factors.
The vast majority of male sub-fertility is idiopathic,
preventing the logical development of an effective treatment.
Copyright © 2023 PeriNess - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.